EVALUATION OF ANIMAL-EXPERIMENTS ON CARCINOGENICITY

被引:0
|
作者
MAXIMILIEN, R
MORIN, M
机构
来源
JOURNAL DE TOXICOLOGIE CLINIQUE ET EXPERIMENTALE | 1991年 / 11卷 / 3-4期
关键词
CARCINOGENICITY; LONG TERM BIOASSAYS; RISK ASSESSMENT; SPECIATION;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In many cases, epidemiological studies demonstrate carcinogenic risk of occupational exposures and industrial processes, but do not allow to assess carcinogenic potential of the various substances involved in exposures (speciation). Expert judgement combining human and animal data is needed for classifying and labelling of the pure substances. For decision aiding purpose, a method was established for reviewing critically experimental carcinogenesis: 1. Standardized toxicological profiles are established according to pure substances, species, strains and administration routes. 2. Methodological evaluation is made using a scheme based on 3 critical parameters: study duration which should extend to the life expectancy of the species under study; sample size, the statistical significance of negative experiments being ascertained depending on size of samples; survival rates of groups, since sufficient numbers of animals should be at risk during most of their life span. 3. Classification of the results for risk assessment, taking into account the relevance of the administration routes.
引用
收藏
页码:147 / 158
页数:12
相关论文
共 50 条
  • [1] Animal carcinogenicity studies: 3. Alternatives to the bioassay
    Knight, A
    Bailey, J
    Balcombe, J
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2006, 34 (01): : 39 - 48
  • [2] Animal carcinogenicity studies: 1. Poor human predictivity
    Knight, A
    Bailey, J
    Balcombe, J
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2006, 34 (01): : 19 - 27
  • [3] Animal carcinogenicity studies: 2. Obstacles to extrapolation of data to humans
    Knight, A
    Bailey, J
    Balcombe, J
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2006, 34 (01): : 29 - 38
  • [4] Understanding arsenic carcinogenicity by the use of animal models
    Wanibuchi, H
    Salim, EI
    Kinoshita, A
    Shen, J
    Wei, M
    Morimura, K
    Yoshida, K
    Kuroda, K
    Endo, G
    Fukushima, S
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 198 (03) : 366 - 376
  • [5] Toxicological evaluation of carcinogenicity of the pyrethroid imiprothrin in rats and mice
    Yamada, Tomoya
    Asano, Hiroyuki
    Miyata, Kaori
    Rhomberg, Lorenz R.
    Haseman, Joseph K.
    Greaves, Peter
    Greim, Helmut
    Berry, Colin
    Cohen, Samuel M.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2019, 105 : 1 - 14
  • [6] Review of alternative methods of carcinogenicity testing and evaluation of human pharmaceuticals
    Van Deun, K
    Van Cauteren, H
    Vandenberghe, J
    Canning, M
    Vanparys, P
    Coussement, W
    ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1997, 16 (04) : 215 - 233
  • [7] Evaluation of the carcinogenicity of 1,1-dichloroethylene (vinylidene chloride)
    Roberts, SM
    Jordan, KE
    Warren, DA
    Britt, JK
    James, RC
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2002, 35 (01) : 44 - 55
  • [8] Assessment of immunosuppressant drug carcinogenicity: standard and alternative animal models
    Hastings, KL
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2000, 19 (04): : 261 - 265
  • [9] Evaluation of potential carcinogenicity of organic chemicals in synthetic turf crumb rubber
    Perkins, Alaina N.
    Inayat-Hussain, Salmaan H.
    Deziel, Nicole C.
    Johnson, Caroline H.
    Ferguson, Stephen S.
    Garcia-Milian, Rolando
    Thompson, David C.
    Vasiliou, Vasilis
    ENVIRONMENTAL RESEARCH, 2019, 169 : 163 - 172
  • [10] Data quality in predictive toxicology: Reproducibility of rodent carcinogenicity experiments
    Gottmann, E
    Kramer, S
    Pfahringer, B
    Helma, C
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2001, 109 (05) : 509 - 514